Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 1
2004 1
2005 1
2006 2
2007 2
2009 5
2010 4
2011 7
2012 4
2013 9
2014 1
2015 2
2016 2
2017 2
2018 5
2019 2
2020 4
2021 5
2022 5
2023 2
2024 4

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

60 results

Results by year

Filters applied: . Clear all
Page 1
Omalizumab for the Treatment of Multiple Food Allergies.
Wood RA, Togias A, Sicherer SH, Shreffler WG, Kim EH, Jones SM, Leung DYM, Vickery BP, Bird JA, Spergel JM, Iqbal A, Olsson J, Ligueros-Saylan M, Uddin A, Calatroni A, Huckabee CM, Rogers NH, Yovetich N, Dantzer J, Mudd K, Wang J, Groetch M, Pyle D, Keet CA, Kulis M, Sindher SB, Long A, Scurlock AM, Lanser BJ, Lee T, Parrish C, Brown-Whitehorn T, Spergel AKR, Veri M, Hamrah SD, Brittain E, Poyser J, Wheatley LM, Chinthrajah RS. Wood RA, et al. Among authors: scurlock am. N Engl J Med. 2024 Mar 7;390(10):889-899. doi: 10.1056/NEJMoa2312382. Epub 2024 Feb 25. N Engl J Med. 2024. PMID: 38407394 Free PMC article. Clinical Trial.
Efficacy and safety of oral immunotherapy in children aged 1-3 years with peanut allergy (the Immune Tolerance Network IMPACT trial): a randomised placebo-controlled study.
Jones SM, Kim EH, Nadeau KC, Nowak-Wegrzyn A, Wood RA, Sampson HA, Scurlock AM, Chinthrajah S, Wang J, Pesek RD, Sindher SB, Kulis M, Johnson J, Spain K, Babineau DC, Chin H, Laurienzo-Panza J, Yan R, Larson D, Qin T, Whitehouse D, Sever ML, Sanda S, Plaut M, Wheatley LM, Burks AW; Immune Tolerance Network. Jones SM, et al. Among authors: scurlock am. Lancet. 2022 Jan 22;399(10322):359-371. doi: 10.1016/S0140-6736(21)02390-4. Lancet. 2022. PMID: 35065784 Free PMC article. Clinical Trial.
The SunBEAm birth cohort: Protocol design.
Keet C, Sicherer SH, Bunyavanich S, Visness C, Fulkerson PC, Togias A, Davidson W, Perry S, Hamrah S, Calatroni A, Robinson K, Dunaway L, Davis CM, Anvari S, Leong-Kee SM, Hershey GK, DeFranco E, Devonshire A, Kim H, Joseph C, Davidson B, Strong NK, Tsuang AJ, Groetch M, Wang J, Dantzer J, Mudd K, Aina A, Shreffler W, Yuan Q, Simmons V, Leung DYM, Hui-Beckman J, Ramos JA, Chinthrajah S, Winn V, Sindher T, Jones SM, Manning NA, Scurlock AM, Kim E, Stuebe A, Gern JE, Singh AM, Krupp J, Wood RA. Keet C, et al. Among authors: scurlock am. J Allergy Clin Immunol Glob. 2023 Aug;2(3):100124. doi: 10.1016/j.jacig.2023.100124. Epub 2023 Jun 3. J Allergy Clin Immunol Glob. 2023. PMID: 37771674 Free PMC article.
Peanut allergenicity.
Scurlock AM, Burks AW. Scurlock AM, et al. Ann Allergy Asthma Immunol. 2004 Nov;93(5 Suppl 3):S12-8. doi: 10.1016/s1081-1206(10)61727-9. Ann Allergy Asthma Immunol. 2004. PMID: 15562869 Review.
Advances in the approach to the patient with food allergy.
Scurlock AM, Jones SM. Scurlock AM, et al. J Allergy Clin Immunol. 2018 Jun;141(6):2002-2014. doi: 10.1016/j.jaci.2017.12.1008. Epub 2018 Mar 8. J Allergy Clin Immunol. 2018. PMID: 29524535 Review.
Safety of Epicutaneous Immunotherapy in Peanut-Allergic Children: REALISE Randomized Clinical Trial Results.
Pongracic JA, Gagnon R, Sussman G, Siri D, Oriel RC, Brown-Whitehorn TF, Green TD, Campbell DE, Anvari S, Berger WE, Bird JA, Chan ES, Cheema A, Chinthrajah RS, Chong HJ, Dowling PJ, Fineman SM, Fleischer DM, Gonzalez-Reyes E, Kim EH, Lanser BJ, MacGinnitie A, Mehta H, Petroni D, Rupp N, Schneider LC, Scurlock AM, Sher LD, Shreffler WG, Sindher SB, Stillerman A, Wood R, Yang WH, Bois T, Sampson HA, Bégin P. Pongracic JA, et al. Among authors: scurlock am. J Allergy Clin Immunol Pract. 2022 Jul;10(7):1864-1873.e10. doi: 10.1016/j.jaip.2021.11.017. Epub 2021 Nov 27. J Allergy Clin Immunol Pract. 2022. PMID: 34848381 Free article. Clinical Trial.
Food allergy oral immunotherapy.
Sood AK, Scurlock AM. Sood AK, et al. Among authors: scurlock am. J Food Allergy. 2020 Sep 1;2(1):75-80. doi: 10.2500/jfa.2020.2.200005. eCollection 2020 Sep. J Food Allergy. 2020. PMID: 39022134 Free PMC article.
Pediatric food allergy and mucosal tolerance.
Scurlock AM, Vickery BP, Hourihane JO, Burks AW. Scurlock AM, et al. Mucosal Immunol. 2010 Jul;3(4):345-54. doi: 10.1038/mi.2010.21. Epub 2010 May 26. Mucosal Immunol. 2010. PMID: 20505663 Free article. Review.
Food Insecurity and Health Inequities in Food Allergy.
Jefferson AA, Davidson L, Scurlock AM, Stern J. Jefferson AA, et al. Among authors: scurlock am. Curr Allergy Asthma Rep. 2024 Apr;24(4):155-160. doi: 10.1007/s11882-024-01134-0. Epub 2024 Feb 29. Curr Allergy Asthma Rep. 2024. PMID: 38421593 Review.
Participant characteristics and safety outcomes of peanut oral immunotherapy in the RAMSES and ARC011 trials.
Ciaccio C, Goldsobel AB, Anagnostou A, Beyer K, Casale TB, Deschildre A, Fernández-Rivas M, Hourihane JO, Krawiec M, Lieberman J, Scurlock AM, Vickery BP, Smith A, Tilles SA, Adelman DC, Brown KR; RAMSES (ARC007) and ARC011 Study Groups:. Ciaccio C, et al. Among authors: scurlock am. Ann Allergy Asthma Immunol. 2022 Dec;129(6):758-768.e4. doi: 10.1016/j.anai.2022.07.033. Epub 2022 Aug 13. Ann Allergy Asthma Immunol. 2022. PMID: 35973655 Free article. Clinical Trial.
60 results